altretamine has been researched along with Peritoneal Carcinomatosis in 1 studies
Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strnad, CM | 1 |
| Grosh, WW | 1 |
| Baxter, J | 1 |
| Burnett, LS | 1 |
| Jones, HW | 1 |
| Greco, FA | 1 |
| Hainsworth, JD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Phase III Trial of Conventional Paclitaxel and Carboplatin Versus Dose Dense Weekly Paclitaxel and Carboplatin in Patients With Newly Diagnosed Stage II-IV Mullerian Carcinoma[NCT00226915] | Phase 3 | 637 participants (Actual) | Interventional | 2003-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for altretamine and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
Peritoneal carcinomatosis of unknown primary site in women. A distinctive subset of adenocarcinoma.
Topics: Adenocarcinoma; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Mod | 1989 |